Evidence map›Paper›PMID 16321794›Full record

ReviewPhilosophical transactions of the Royal Society of London. Series B, Biological sciences2005

A central role for ROS in the functional remodelling of L-type Ca2+ channels by hypoxia.

Chris Peers, Jason L Scragg, John P Boyle, Ian M Fearon, Shafeena C Taylor, Kim N Green, Nicola J Webster, Martin Ramsden, Hugh A Pearson

Open access · greenAbstract readReview
In one paragraph

Review in Philosophical transactions of the Royal Society of London. Series B, Biological sciences, 2005. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.5field-weighted citation impact, top 34% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 22 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 5 institutions in 3 countries.

Chris PeersUniversity of Leeds School of Medicine Worsley Building, Leeds LS2 9JT, UK. c.s.peers@leeds.ac.uk
Jason L Scragg
John P Boyle
Ian M Fearon
Shafeena C Taylor
Kim N Green
Nicola J Webster
Martin Ramsden
Hugh A Pearson
University of Leeds · GBUniversity of Alberta · CAUniversity of California System · USUniversity of Manchester · GBUniversity of Minnesota · US

Funding

Wellcome Trust
6 · The paper itself

Abstract

Periods of prolonged hypoxia are associated clinically with an increased incidence of dementia, the most common form of which is Alzheimer's disease. Here, we review recent studies aimed at providing a cellular basis for this association. Hypoxia promoted an enhanced secretory response of excitable cells via formation of a novel Ca2+ influx pathway associated with the formation of amyloid peptides of Alzheimer's disease. More strikingly, hypoxia potentiated Ca2+ influx specifically through L-type Ca2+ channels in three distinct cellular systems. This effect was post-transcriptional, and evidence suggests it occurred via increased formation of amyloid peptides which alter Ca2+ channel trafficking via a mechanism involving increased production of reactive oxygen species by mitochondria. This action of hypoxia is likely to contribute to dysregulation of Ca2+ homeostasis, which has been proposed as a mechanism of cell death in Alzheimer's disease. We suggest, therefore, that our data provide a cellular basis to account for the known increased incidence of Alzheimer's disease in patients who have suffered prolonged hypoxic episodes.

Indexed as

AmyloidApoptosisCalcium Channels, L-TypeDementiaExocytosisHomeostasisHumansHypoxiaMitochondriaProtein Processing, Post-TranslationalReactive Oxygen SpeciesAmyloidCalcium Channels, L-TypeReactive Oxygen Species

Identifiers

PMID16321794
PMCPMC1569587
OpenAlexW2133058055

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.